Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

525
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
525
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

403
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
403
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

513
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
513
Actuarial Approach01:20

Actuarial Approach

191
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
191
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

393
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
393
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

713
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
713

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

To Determine the Prevalence and Correlation of Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease.

Indian journal of public health·2026
Same author

Proteomic markers enhance mortality prediction in heart failure.

European heart journal·2026
Same author

Refining Aesthetics and Volume: A Retrospective Analysis of Our Experience With Autoaugmentation Mastopexy.

Annals of plastic surgery·2026
Same author

Enhancing Cleavage Aesthetics in Patients Seeking Breast Augmentation: Surgical Technique and Key Considerations.

Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India·2026
Same author

Corrigendum to: Migrasomes: A Novel Target for Cancer Treatment.

Current cancer drug targets·2026
Same author

Evolving spectrum and outcomes of infective endocarditis in North India: A comparative analysis between people who inject drugs and those who do not.

Indian heart journal·2026

Related Experiment Video

Updated: Nov 19, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.2K

Initial experiences regarding COVID19 mortality in Punjab-A mixed method analysis.

Anurag Chaudhary1, Priya Bansal1, Vikram K Gupta1

  • 1Department of Community Medicine, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

Journal of Family Medicine and Primary Care
|February 3, 2021
PubMed
Summary

Delays in COVID-19 diagnosis and treatment, particularly for patients with multiple comorbidities, contributed to mortality. While initial health-seeking behavior was adequate, hospital system issues and communication gaps impacted care.

Keywords:
COVID-19deathsdelayexperiences of relatives

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.5K

Related Experiment Videos

Last Updated: Nov 19, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.2K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.5K

Area of Science:

  • Medical Research
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic created significant healthcare challenges and information demands.
  • Understanding delays in diagnosis and treatment is crucial for improving patient outcomes.
  • Family perspectives on care experiences offer valuable insights into healthcare system performance.

Purpose of the Study:

  • To identify factors contributing to delays in COVID-19 diagnosis and treatment.
  • To explore family members' experiences with healthcare facilities for deceased COVID-19 patients.
  • To analyze the impact of comorbidities on COVID-19 mortality.

Main Methods:

  • Retrospective study of 48 laboratory-confirmed COVID-19 deaths in Punjab, India (March-June 2020).
  • Data collection included socio-demographic profiles, clinical timelines, and medical aid.
  • Interviews with family members of deceased patients explored their experiences and perceptions.

Main Results:

  • The mean age of deceased individuals was 56.3 years; 82.2% had three or more comorbidities.
  • Median time from symptom onset to first medical contact was 1 day, and to diagnosis confirmation was 5 days.
  • Qualitative themes revealed delays in care, dissatisfaction with hospital systems, and poor communication.

Conclusions:

  • Comorbidities represent a significant risk factor for COVID-19 mortality.
  • Initial patient health-seeking behavior post-symptom onset was generally satisfactory.
  • Systemic issues and communication gaps within healthcare facilities require attention to improve COVID-19 patient management.